Immunovant shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $438k | 27k | 16.13 |
| 2024-09-30 | $702k | 25k | 28.50 |
| 2024-06-30 | $391k | 15k | 26.38 |
| 2023-12-31 | $369k | 8.8k | 42.12 |
| 2023-06-30 | $621k | 33k | 18.97 |
| 2022-09-30 | $531k | 95k | 5.58 |
| 2022-06-30 | $155k | 40k | 3.89 |
| 2021-12-31 | $346k | 41k | 8.51 |
| 2021-09-30 | $705k | 81k | 8.69 |
| 2020-12-31 | $239k | 5.2k | 46.18 |